{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:15:54Z","timestamp":1788340554286,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103446"],"award-info":[{"award-number":["P20GM103446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM114736"],"award-info":[{"award-number":["P30GM114736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.omtn.2018.05.019","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T15:12:21Z","timestamp":1530803541000},"page":"420-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS"],"prefix":"10.1016","volume":"12","author":[{"given":"Stephanie","family":"Tantzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sperle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Kenaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.05.019_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg775","article-title":"Listening to silence and understanding nonsense: exonic mutations that affect splicing","volume":"3","author":"Cartegni","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.2649","article-title":"The pathobiology of splicing","volume":"220","author":"Ward","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.omtn.2018.05.019_bib3","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1126\/science.1090100","article-title":"Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays","volume":"302","author":"Johnson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.05.019_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/978-0-387-77374-2_13","article-title":"Alternative splicing in disease","volume":"623","author":"Orengo","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtn.2018.05.019_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrm1645","article-title":"Understanding alternative splicing: towards a cellular code","volume":"6","author":"Matlin","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2018.05.019_bib6","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1128\/MCB.24.24.10505-10514.2004","article-title":"Influence of RNA secondary structure on the pre-mRNA splicing process","volume":"24","author":"Buratti","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtn.2018.05.019_bib7","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1261\/rna.1069408","article-title":"Conserved RNA secondary structures promote alternative splicing","volume":"14","author":"Shepard","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2018.05.019_bib8","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1093\/hmg\/ddu271","article-title":"PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1\/DM20 alternative splicing","volume":"23","author":"Taube","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2164-12-90","article-title":"GC content around splice sites affects splicing through pre-mRNA secondary structures","volume":"12","author":"Zhang","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.omtn.2018.05.019_bib10","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1073\/pnas.84.16.5665","article-title":"Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin","volume":"84","author":"Nave","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.05.019_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000111853","article-title":"Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain","volume":"12","author":"LeVine","year":"1990","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.omtn.2018.05.019_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.1992.tb09378.x","article-title":"DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse","volume":"58","author":"Timsit","year":"1992","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtn.2018.05.019_bib13","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1523\/JNEUROSCI.20-11-04002.2000","article-title":"The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin","volume":"20","author":"Stecca","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2018.05.019_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/humu.20276","article-title":"Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes","volume":"27","author":"Hobson","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2018.05.019_bib15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.55.8.1089","article-title":"Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease","volume":"55","author":"Hobson","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2018.05.019_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.10320","article-title":"A PLP splicing abnormality is associated with an unusual presentation of PMD","volume":"52","author":"Hobson","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jcb.20692","article-title":"PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer","volume":"97","author":"Wang","year":"2006","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omtn.2018.05.019_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2008.09.001","article-title":"Deletion of a splicing enhancer disrupts PLP1\/DM20 ratio and myelin stability","volume":"214","author":"Wang","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ana.10466","article-title":"Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy","volume":"53","author":"Shy","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-6-40","article-title":"Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations","volume":"6","author":"Grossi","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2018.05.019_bib21","first-page":"220","article-title":"A novel mutation in the variably spliced region of the human PLP gene associated with classical Pelizaeus-Merzbacher disease, Mutation and Polymorphism Report #17","volume":"12","author":"Bartholomew","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2018.05.019_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2013.08.030","article-title":"Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease","volume":"335","author":"Laukka","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.omtn.2018.05.019_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.45.2.394","article-title":"A novel mutation in exon 3 of the proteolipid protein gene in Pelizaeus-Merzbacher disease","volume":"45","author":"Pratt","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2018.05.019_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/humu.9314","article-title":"Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease","volume":"25","author":"H\u00fcbner","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2018.05.019_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajmg.1320430335","article-title":"New variant in exon 3 of the proteolipid protein (PLP) gene in a family with Pelizaeus-Merzbacher disease","volume":"43","author":"Pratt","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib26","first-page":"A209","article-title":"The role of proteolipid protein gene mutations in Pelizaeus-Merzbacher disease","volume":"51","author":"Bridge","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0883073813492387","article-title":"Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease","volume":"29","author":"La\u0161\u0161uthov\u00e1","year":"2014","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.braindev.2009.11.004","article-title":"Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation","volume":"32","author":"Osaka","year":"2010","journal-title":"Brain Dev."},{"key":"10.1016\/j.omtn.2018.05.019_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.ejhg.5200537","article-title":"Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations","volume":"8","author":"Cailloux","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/acn3.203","article-title":"Altered PLP1 splicing causes hypomyelination of early myelinating structures","volume":"2","author":"Kevelam","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0032-1306388","article-title":"Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders","volume":"32","author":"Hobson","year":"2012","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib32","series-title":"GeneReviews","article-title":"PLP1-Related Disorders","author":"Hobson","year":"2013"},{"key":"10.1016\/j.omtn.2018.05.019_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0896-6273(02)01045-0","article-title":"The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease","volume":"36","author":"Southwood","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2018.05.019_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1523\/JNEUROSCI.17-01-00181.1997","article-title":"Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath","volume":"17","author":"Gow","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2018.05.019_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.140.4.925","article-title":"Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease","volume":"140","author":"Gow","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2018.05.019_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/brain\/awf043","article-title":"Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation","volume":"125","author":"Garbern","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2018.05.019_bib37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.50.6.1749","article-title":"Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease","volume":"50","author":"Sistermans","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2018.05.019_bib38","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1093\/hmg\/ddr333","article-title":"Specific correction of a splice defect in brain by nutritional supplementation","volume":"20","author":"Shetty","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.05.019_bib39","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1074\/jbc.M110.183970","article-title":"Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA","volume":"286","author":"Zhang","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2018.05.019_bib40","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/ncomms3044","article-title":"Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules","volume":"4","author":"Childs-Disney","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.05.019_bib41","doi-asserted-by":"crossref","first-page":"e73633","DOI":"10.1371\/journal.pone.0073633","article-title":"Restoration of the normal splicing pattern of the PLP1 gene by means of an antisense oligonucleotide directed against an exonic mutation","volume":"8","author":"Regis","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.05.019_bib42","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.019_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.omtn.2018.05.019_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/hum.2012.225","article-title":"Antisense oligonucleotides for the treatment of spinal muscular atrophy","volume":"24","author":"Porensky","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.019_bib45","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2018.05.019_bib46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0883073815627882","article-title":"Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience","volume":"31","author":"Hach\u00e9","year":"2016","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2018.05.019_bib48","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2018.05.019_bib49","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1460-9568.1995.tb01115.x","article-title":"Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Jung","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.omtn.2018.05.019_bib50","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jnr.22625","article-title":"Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines","volume":"89","author":"Pereira","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.omtn.2018.05.019_bib51","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1074\/jbc.M809373200","article-title":"Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein\/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs","volume":"284","author":"Wang","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2018.05.019_bib52","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1093\/nar\/gkm387","article-title":"PLP\/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes","volume":"35","author":"Wang","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.019_bib53","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1074\/jbc.M110.199927","article-title":"G Run-mediated recognition of proteolipid protein and DM20 5\u2032 splice sites by U1 small nuclear RNA is regulated by context and proximity to the splice site","volume":"286","author":"Wang","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2018.05.019_bib54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/156802607780487740","article-title":"Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity","volume":"7","author":"Summerton","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.omtn.2018.05.019_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks539","article-title":"SIFT web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.019_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2018.05.019_bib57","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.019_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2018.05.019_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2018.05.019_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1742-2094-10-146","article-title":"Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain","volume":"10","author":"Bachstetter","year":"2013","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.omtn.2018.05.019_bib61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/emmm.200900057","article-title":"Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease","volume":"2","author":"Edgar","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2018.05.019_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awg061","article-title":"Axonal damage: a key predictor of outcome in human CNS diseases","volume":"126","author":"Medana","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2018.05.019_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-9-33","article-title":"Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease","volume":"9","author":"Landel","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtn.2018.05.019_bib64","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1523\/JNEUROSCI.1336-13.2013","article-title":"Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication","volume":"33","author":"Clark","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2018.05.019_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/B978-0-444-64076-5.00045-4","article-title":"Neurogenetics of Pelizaeus-Merzbacher disease","volume":"148","author":"Os\u00f3rio","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.omtn.2018.05.019_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/glia.10014","article-title":"Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development","volume":"37","author":"Sp\u00f6rkel","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.omtn.2018.05.019_bib67","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.201415598","article-title":"Molecular synapomorphies resolve evolutionary relationships of extant jawed vertebrates","volume":"98","author":"Venkatesh","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.05.019_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","article-title":"Exon skipping: a first in class strategy for Duchenne muscular dystrophy","volume":"17","author":"Niks","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"56","key":"10.1016\/j.omtn.2018.05.019_bib69","first-page":"2968","article-title":"Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice","author":"Glascock","year":"2011","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtn.2018.05.019_bib70","unstructured":"R Core Team (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, http:\/\/www.R-project.org."},{"key":"10.1016\/j.omtn.2018.05.019_bib71","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.47.5.1333","article-title":"Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease","volume":"47","author":"Nance","year":"1996","journal-title":"Neurology"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:30:26Z","timestamp":1788337826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118301185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":71,"alternative-id":["S2162253118301185"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.05.019","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}